CIK 0000914475 · Large accelerated filer
NEUROCRINE BIOSCIENCES INC
Sign in to watch- Ticker
- NBIX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330525145
- Phone
- (858) 617-7600
- Business address
- 6027 EDGEWOOD BEND COURT, SAN DIEGO, CA, 92130
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,162,347
- in 4 filings, $3.2M under 10b5-1 plans
Net −$3,162,347. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-08 | GORMAN KEVIN CHARLES Chief Executive Officer | Sale 10b5-1 | −2,274 | $134.15 | $305K | 506,962 |
| 2024-02-08 | Gano Kyle Chief Business Development Off | Sale 10b5-1 | −980 | $134.20 | $132K | 133,952 |
| 2024-02-08 | BENEVICH ERIC Chief Commercial Officer | Sale 10b5-1 | −980 | $134.19 | $132K | 39,631 |
| 2024-02-08 | ABERNETHY MATT Chief Financial Officer | Sale 10b5-1 | −980 | $134.21 | $132K | 30,314 |
| 2024-02-06 | Boyer David W. Chief Corp. Affairs Officer | Sale 10b5-1 | −240 | $141.96 | $34K | 5,110 |
| 2024-02-06 | Boyer David W. Chief Corp. Affairs Officer | Sale 10b5-1 | −216 | $141.96 | $31K | 4,894 |
| 2024-02-06 | Cooke Julie Chief Human Resources Officer | Sale 10b5-1 | −640 | $142.17 | $91K | 17,838 |
| 2024-02-06 | Cooke Julie Chief Human Resources Officer | Sale 10b5-1 | −575 | $141.96 | $82K | 17,263 |
| 2024-02-06 | ROBERTS EIRY Chief Medical Officer | Sale 10b5-1 | −1,121 | $142.24 | $159K | 21,837 |
| 2024-02-06 | Lippoldt Darin Chief Legal Officer | Sale 10b5-1 | −1,041 | $142.17 | $148K | 37,939 |
| 2024-02-06 | GORMAN KEVIN CHARLES Chief Executive Officer | Sale 10b5-1 | −3,040 | $142.18 | $432K | 504,919 |
| 2024-02-06 | Gano Kyle Chief Business Development Off | Sale 10b5-1 | −1,600 | $142.20 | $228K | 133,072 |
| 2024-02-06 | BENEVICH ERIC Chief Commercial Officer | Sale 10b5-1 | −1,280 | $142.12 | $182K | 38,751 |
| 2024-02-06 | ABERNETHY MATT Chief Financial Officer | Sale 10b5-1 | −1,280 | $142.19 | $182K | 29,434 |
| 2024-02-01 | Delaet Ingrid Chief Regulatory Officer | Sale 10b5-1 | −623 | $139.77 | $87K | 6,865 |
| 2024-01-31 | ROBERTS EIRY Chief Medical Officer | Sale 10b5-1 | −1,457 | $140.79 | $205K | 20,832 |
| 2024-01-31 | Onyia Jude Chief Scientific Officer | Sale 10b5-1 | −126 | $141.94 | $18K | 11,843 |
| 2024-01-31 | Lippoldt Darin Chief Legal Officer | Sale 10b5-1 | −1,250 | $140.65 | $176K | 37,005 |
| 2024-01-31 | GORMAN KEVIN CHARLES Chief Executive Officer | Sale 10b5-1 | −2,707 | $140.69 | $381K | 502,188 |
| 2024-01-31 | Gano Kyle Chief Business Development Off | Sale 10b5-1 | −1,541 | $140.70 | $217K | 131,635 |
Page 39 of 49 · 963 trades